HOME >> BIOLOGY >> NEWS
UCSB among team awarded $12.5 million to develop nanoscale systems for early diagnosis

July 14, 2005 Santa Barbara, Calif. A partnership of scientists from the College of Engineering at UC Santa Barbara, Washington University in St. Louis and UC Berkeley have been awarded $12.5 million to develop nanoscale agents to provide early diagnosis and treatment of acute pulmonary and systemic vascular injury over the next five years. The organizations were selected as a collaborative "Program of Excellence in Nanotechnology" (PEN) by the National Heart Lung and Blood Institute of the National Institutes of Health (NIH).

The team, led at UCSB by Professor Craig Hawker, Director of the Materials Research Laboratory, and coordinated by Professor Karen Wooley at Washington University in St. Louis will use nanoscale materials as carriers for diagnostic systems and to deliver therapeutic agents. Hawker and Wooley working with Professor Jean Frechet, PhD, at the University of California, Berkeley, will be developing a way to trigger a breakdown of the nanoparticles after a payload, such as a drug or antiviral agent, is delivered directly to a diseased zone. Targeted nanoparticles will search out arteries that are under stress or are diseased.

The nanoscale designs are based on the concept that advanced nanotechnologies can help overcome inherent limitations of molecular imaging and therapeutic gene transfer.

"I think part of the reason we received this grant was due to UCSB's excellence in soft materials and in engineering," said Hawker. Acute vascular injury and inflammation have been chosen as general targets since they affect tissues broadly, including those of the lung and cardiovascular system.


'"/>

Contact: Barbara Bronson Gray
bbgray@sbcglobal.net
818-889-5415
University of California - Santa Barbara
14-Jul-2005


Page: 1

Related biology news :

1. High rates of HIV infection documented among young Nepalese girls sex-trafficked to India
2. Injection drug use and HIV and HCV infections among Ontario prison inmates
3. Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners
4. Liverpool amongst first in UK to install unique DNA sequencing technology
5. New research shows vaginal bacteria vary among healthy women, need customized treatment
6. Study investigates divorce among Galapagos seabirds
7. OSA symptoms more common among African-American women than Caucasians
8. Dietary vitamin B6, B12 and folate, may decrease pancreatic cancer risk among lean people
9. Lonesome George is not alone among Galpagos tortoises
10. Spiteful soldiers and sex ratio conflict among parasitoid wasps
11. New evidence of human culture among primates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... PA’s, RN’s, LPN’s, MA's and Administrative staff. , This full day course is ... biologics. The course will expose your staff to regenerative medicine procedures and processing ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek ... and to accelerate Lifecycle’s continued growth and expansion. , With over 20 ...
Breaking Biology News(10 mins):
(Date:7/31/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... adipose tissue-derived stem cells to treat or prevent inflammation at the site of ... specifically, VetStem has been issued similar patents that cover the United States as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne ... of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. ... assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... 2018 , ... R3 Stem Cell is now offering regenerative therapies for COPD ... Double Board Certified providers, with outcomes significantly improving patient quality of life. , Traditional ... nothing to help repair and regenerate damaged lung tissues. Stem cell therapy for ...
Breaking Biology Technology:
Cached News: